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Abstract
We investigated the physiological consequences of one of the most extreme exercises realized by humans in race
conditions: a 166-km mountain ultra-marathon (MUM) with 9500 m of positive and negative elevation change. For this
purpose, (i) the fatigue induced by the MUM and (ii) the recovery processes over two weeks were assessed. Evaluation of
neuromuscular function (NMF) and blood markers of muscle damage and inflammation were performed before and
immediately following (n=22), and 2, 5, 9 and 16 days after the MUM (n=11) in experienced ultra-marathon runners. Large
maximal voluntary contraction decreases occurred after MUM (235% [95% CI: 228 to 242%] and 239% [95% CI: 232 to
246%] for KE and PF, respectively), with alteration of maximal voluntary activation, mainly for KE (219% [95% CI: 27t o
232%]). Significant modifications in markers of muscle damage and inflammation were observed after the MUM as
suggested by the large changes in creatine kinase (from 144694 to 13,633612,626 UI L
21), myoglobin (from 32622 to
1,43261,209 mgL
21), and C-Reactive Protein (from ,2.0 to 37.7626.5 mg L
21). Moderate to large reductions in maximal
compound muscle action potential amplitude, high-frequency doublet force, and low frequency fatigue (index of
excitation-contraction coupling alteration) were also observed for both muscle groups. Sixteen days after MUM, NMF had
returned to initial values, with most of the recovery process occurring within 9 days of the race. These findings suggest that
the large alterations in NMF after an ultra-marathon race are multi-factorial, including failure of excitation-contraction
coupling, which has never been described after prolonged running. It is also concluded that as early as two weeks after such
an extreme running exercise, maximal force capacities have returned to baseline.
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Introduction
Walking and running are the most common modes of
locomotion over the world in the daily life but these activities
are also competitive events over a large range of distances.
Running and walking for extreme durations, i.e. the so-called ultra-
marathons, have become increasingly popular in the last few years
throughout the world, particularly in the USA, Europe, Japan and
South Africa. For instance, it was recently shown that the number
of finishes in 161-km ultra-marathons increased exponentially in
North America over the period 1977–2008 through a combination
of an increase in the average annual number of races completed by
each individual and an increase in the number of races organized
every year [1]. Despite the recent success of ultra-endurance
running, particularly in Europe, the physiological consequences of
ultra-marathons are poorly understood. Investigating fatigue in
ultra-marathons is a unique occasion to study human physiology
as it is stretched towards it endurance limits [2,3]. In recent years,
only a few studies have been dedicated to this very unusual
exercise. This is important because the aetiology of fatigue
depends on the type of exercise [4], particularly intensity and
duration. Other critical task variables include muscle groups
involved, activation patterns and types of muscle contraction so
the type of locomotion under consideration is also critical.
Neuromuscular fatigue is an exercise-related decrease in the
maximal voluntary force or power of a muscle or muscle group,
whether or not the task can be sustained. This potentially involves
processes at all levels of the motor pathway from the brain to
skeletal muscle. General discussions of potential factors involved in
neuromuscular fatigue in the case of prolonged running exercises
can be found elsewhere [2,5,6,7]. Briefly, large central fatigue (i.e.
reduced maximal voluntary activation) was observed after running
5 to 24 h [2,6,8], this activation deficit likely dependant on the
muscle group tested, i.e. plantar flexors (PF) vs. knee extensors (KE)
[2]. The implication of a central mechanism does not mean an
absence of peripheral fatigue but seems to confine this type of
alteration to a moderate level in the case of ultra-long exercise.
Only one study has been conducted in exercise of extreme
duration such as a 24 h-run [2]. This experiment involved level
running (treadmill) so the combined effects of elevation (i.e. change
PLoS ONE | www.plosone.org 1 February 2011 | Volume 6 | Issue 2 | e17059in altitude over a course) plus extreme duration are unknown.
Particularly, no study on prolonged running [7,8,9] - including the
24 h experiment [2] - has detected low frequency fatigue (LFF),
which has been linked to E–C coupling alteration and muscle
damage [10,11]. Since evidence of muscle damage after prolonged
running exists [12], this result was unexpected and led to the
conclusion that a minimal exercise intensity is necessary to induce
mechanical and metabolic disturbances that may promote the
development of LFF [2]. Nevertheless, it can be hypothesized that
the combination of extreme duration and large sections of
downhill running (i.e. eccentric contractions of lower-limb extensor
muscles) could be sufficient to induce LFF. Thus, the first purpose
of the present study was to investigate the aetiology of KE/PF
fatigue (neuromuscular function, blood parameters) in trained
subjects performing a mountain ultra-marathon (MUM) charac-
terized by an extreme distance/duration (166 km) and a large
positive/negative elevation change (+/2 9500 m). Specifically, we
hypothesized that neuromuscular function alterations, especially at
the peripheral level, would be higher than after a running exercise
of similar distance but on flat terrain [2]. To the best of our
knowledge, no epidemiologic studies have been conducted on
ultra-marathon runners, nor is experimental data available about
the recovery processes following this type of extreme exercise.
Specifically, it is currently unknown how much time is necessary to
recover from such physical challenges. The second aim of the
present study was to assess the recovery kinetics of neuromuscular
function (NMF) by testing subjects 2, 5, 9 and 16 days after an
international MUM.
Methods
Participants
Twenty-two male runners participated to this study after
medical examination. Their main characteristics are given in
Table 1. Thirty-four subjects were initially recruited but only 22
(i.e. 65%) were able to complete the MUM and took part to the
first part of the study (fatigue). This finishers/starters ratio for the
subjects of the present study was similar to the ratio when all race
participants are considered (64%, data from the race organiza-
tion). All the subjects were experienced ultra-marathon runners
since to be registered to the MUM supporting the study (the
North-Face Ultra-Trail du Mont-blanc 2009), one has to complete
at least one MUM and one mountain marathon in the two years
preceding the race. On average, the subjects had 13.3 years of
training history in running and 5.0 years of ultra-endurance
experience. Eleven of the 22 subjects participated to the second
part of the study (recovery phase, see below). Their main
characteristics, also presented in Table 1, are similar to the group
of 22 subjects. There was no significant difference between the two
groups for any of these characteristics.
Ethics Statement
All subjects were fully informed of the procedure and the risks
involved and gave their written consent. They were also allowed to
withdraw from the study at will. The experiment was conducted
according to the Declaration of Helsinki. Approval for the project
was obtained from the local ethics committee (Comite ´d e
Protection des Personnes Sud-Est 1, France).
Experimental design
An overview of the experiment is given in Figure 1A. The
participants came into the laboratory three times for the subjects
performing only the fatigue measurements (i.e. pre- and post-race,
n=22) and seven times for the subjects participating to the whole
experiment (i.e. fatigue & recovery parts, n=11). The first visit was
performed 4 to 7 weeks before the second session (pre-race
measurements) and consisted in a medical examination and
determination of body mass, height and percentage of body fat
(skinfold thickness measurements). During this first session, the
subjects also performed a maximal test on a motorized treadmill
(Gymrol S2500, HEF Tecmachine, Andrezieux-Boutheon,
France), that aimed at determining anaerobic threshold, maximal
oxygen uptake ( _ V VO2max) and the velocity associated with
_ V VO2max (V _ V VO2max). The initial velocity was set at 4 to 6 km ? h
21
depending on the runner level of performance and the slope
was +10%. The test consisted in a maximal continuous
incremental test, the speed being progressively increased by
1k m? h
21 every 2 min. The last stage entirely completed was
considered as V _ V VO2max. The highest _ V VO2value (Douglas bag
method) was considered as _ V VO2max. Detailed procedure of
_ V VO2measurements can be found elsewhere [13]. During the first
visit, the subjects were also fully informed regarding the
experimental procedures. Particular attention was paid to
familiarize them with the maximal voluntary contractions
(MVC) and electrical stimulation of the KE and PF muscles.
The subjects repeated trials of the procedures until they were able
to produce consistent results.
The international race supporting the study was the North-Face
Ultra-Trail du Mont-blanc 2009. About 2500 participants took
part to the race in 2009. It consisted in running/walking 166 km
with a total positive and negative elevation of 9500 m. The race
characteristics (course profile, altitude) are detailed in Figure 1B.
The second (pre-race) an third (post-race) sessions, as well as
sessions #4 to 7 performed 2, 5, 9 and 16 days after the race (D+2,
D+5, D+9 and D+16, respectively) were nearly identical. The only
difference was the fact that no warm-up was performed in session
#3 (immediately after the race) for obvious reasons while 6-min
cycling at about 50% _ V VO2max was done before NMF evaluation in
the other sessions. The NMF was evaluated 2 to 10 days before the
race (PRE), within 20613 min after the race (POST) as well as at
D+2, D+5, D+9 and D+16 for the 11 subjects who performed the
second part of the study. After the delivery of 3 single electrical
stimulations to evoke unpotentiated twitches, the NMF evaluation
consisted in determining the isometric MVC of KE and PF to
provide a global index of fatigue. Maximal voluntary activation
levels of KE and PF was assessed using superimposed high-
frequency (100 Hz) doublets to detect central fatigue. Finally,
evoked stimulations were delivered to the relaxed muscle in a
potentiated state to determine the extent and origin of peripheral
fatigue (see below and typical trace in Figure 2). The set (MVC +
Table 1. Main characteristics of the subjects.
Age
(y)
Height
(m)
Mass
(kg)
Body
fat (%)
_ V VO2max
(ml ? kg
21 ?
min
21)
Training
(h ?
wk
21)
Fatigue 40.2 1.78 73.4 12.6 54.1 9.0
(n=22) 67.4 60.07 66.4 63.3 64.3 63.8
Recovery 37.9 1.78 76.0 13.3 55.0 7.7
(n=11) 67.2 60.07 66.5 63.3 64.8 62.3
Data are mean values 6 SD. Training was computed from May 1
st to the race
day (end of August).
Twenty-two subjects performed only the pre- and post-race measurements
(Fatigue) and 11 of these 22 participated to the whole experiment, i.e. PRE/
POST/D+2/D+5/D+9/D+16 (Recovery).
doi:10.1371/journal.pone.0017059.t001
Neuromuscular Consequences of Extreme Running
PLoS ONE | www.plosone.org 2 February 2011 | Volume 6 | Issue 2 | e17059superposed stimulation; high-frequency doublet, low-frequency
doublet, single twitches) was repeated three times for both muscle
groups. Incidental training (30 min to 1 h of light training per
week) was performed by 7 of the 11 subjects between POST and
D+9. Between D+9 and D+16, the subjects reported 74684 min
of light training. Body mass was measured without shoes
immediately before race and at the beginning of the testing
session at POST, D+2, D+5, D+9 and D+16.
Voluntary contractions. During all the MVCs, the subjects
were strongly encouraged. For the KE testing, the subjects were
seated in the frame of a Cybex II (Ronkonkoma, NY) and Velcro
straps were strapped across the chest and hips to avoid lateral and
frontal displacements. Subjects were also instructed to grip the seat
during the voluntary contractions to further stabilize the pelvis.
The KE muscles mechanical response was recorded with a strain
gauge (SBB 200 Kg, Tempo Technologies, Taipei, Taiwan)
located at the level of the external malleolus. Torque values
were obtained from force measured by the strain gauge multiplied
by the lever arm, i.e. knee-malleolus distance. All measurements
were taken from the subject’s right leg, with the knee and hip
flexed at 90 degrees from full extension. PF muscles were tested
with an instrumented pedal (CS1060 300 Nm, FGP Sensors, Les
Clayes Sous Bois, France). For the PF testing, the subjects were
seated in the frame of a Cybex II (Ronkonkoma, NY) similar to
that used for KE. Velcro straps were also strapped across the chest
and hips to avoid lateral and frontal displacements as well as across
the forefoot to limit heel lift during the MVC. The hip, knee and
ankle angles were set at 90 degrees from full extension.
Electrical stimulation. After femoral (for KE) and posterior
tibial nerve (PF) detection with a ball probe cathode pressed into
the femoral triangle and the popliteal fossa, respectively, electrical
stimulation was applied percutaneously to the motor nerve via a
self-adhesive electrode pressed manually (10-mm diameter, Ag-
AgCl, Type 0601000402, Contro ˆle Graphique Medical, Brie-
Comte-Robert, France). The anode, a 1065 cm self-adhesive
stimulation electrode (Medicompex SA, Ecublens, Switzerland),
was located either in the gluteal fold (for KE) or on the patella (for
PF). A constant current stimulator (Digitimer DS7A,
Hertfordshire, United Kingdom) was used to deliver a square-
wave stimulus of 1000 ms duration with maximal voltage of 400 V.
The optimal stimulation intensity (45.069.7 mA; range: 30 mA to
65 mA on KE and 46.566.5 mA, 35 mA to 60 mA on PF) was
determined from maximal twitch torque measurement (see below)
and was reassessed before each session including POST. The
stimulating intensity was supramaximal (150% of optimal
intensity). For both KE and PF, stimulations included
Figure 1. General view of the experiment and race profile. General view of the experimental testing (panel A) and the course of the race
supporting the study (panel B).
doi:10.1371/journal.pone.0017059.g001
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interstimulus interval) and a set of potentiated high-frequency
doublet, low frequency doublet (10 Hz, 100-ms interstimulus
interval) and single twitch (see Figure 2 for timing) delivered to the
relaxed muscle in a potentiated state.
Electromyographic recordings. The EMG signals of the
right vastus lateralis (VL) and soleus (SOL) were recorded using
bipolar silver chloride surface electrodes of 10-mm diameter (Type
0601000402, Contro ˆle Graphique Medical, Brie-Comte-Robert,
France) during the MVC and electrical stimulation. The recording
electrodes were taped lengthwise on the skin over the muscle belly
following SENIAM recommendations [14], with an interelectrode
distance of 25 mm. The position of the electrodes was marked on
the skin so that they could be fixed in the same place after the race
and during measurements in the two-week recovery period. The
reference electrode was attached to the patella (for VL EMG) or
malleolus (for SOL EMG). Low impedance (Z,5k V) at the skin-
electrode surface was obtained by abrading the skin with thin sand
paper and cleaning with alcohol. EMG data were recorded with
PowerLab system (16/30 - ML880/P, ADInstruments, Bella Vista,
Australia) with a sampling frequency of 2000 Hz. The EMG signal
was amplified with octal bio-amplifier (Octal Bioamp, ML138,
ADInstruments) with a bandwidth frequency ranging from 5 to
500 Hz (input impedance = 200 MV, common mode rejection
ratio = 85 dB, gain = 1000), transmitted to the PC and analyzed
with LabChart 6 software (ADInstruments).
Blood samples. Peripheral venous blood samples were taken
from an antecubital vein of participants before and immediately
after completing the MUM as well as during recovery. Samples
were drawn into nonadditive tubes under sterile conditions. Serum
was separated from whole blood by centrifugation at 1,000 g for
10 min at room temperature. An OLYMPUS 2700 analyzer
(Beckman Coulter, Brea, USA) was used for simultaneous assay
with reagents from the manufacturer of sodium, potassium, total
protein, urea, creatinine, calcium, glucose, C-Reactive Protein
(CRP), Aspartate Aminotransferase, Alanine Aminotransferase,
Creatine Kinase (CK) and Lactate Dehydrogenase (LDH).
Myoglobin was measured by access immunoassay (Beckman
Coulter, Brea, USA).
Experimental variables and data analysis
M-wave. M-wave peak-to-peak amplitude and duration were
considered. They were analyzed from the three single potentiated
twitches evoked on the relaxed muscle.
Mechanical responses to nerve stimulation. The
amplitude of the potentiated high frequency doublet (PDb100),
the ratio of paired stimulation peak forces at 10 Hz over 100 Hz
(Db10:100) and the amplitude of the potentiated twitch peak
torque (Pt) that followed the two doublets (see figure 2) were
analyzed for both KE and PF. For these three parameters (PDb100,
Db10:100 and Pt), the average value computed from the three sets
was considered. The use of Db10:100 to assess LFF has been
recently validated [15]. Potentiation was also calculated as the
ratio of potentiated to unpotentiated Pt.
Maximal voluntary contractions and maximal activation
level. The highest values of the three 5s-MVC was considered
for each muscle group. During the voluntary contractions,
electrical stimulations were superimposed to evaluate the level of
activation. The technique was adapted from the twitch
interpolation technique [16] and consisted in superimposing a
high frequency doublet at supramaximal intensity on the isometric
plateau. The control high-frequency doublet was delivered to the
Figure 2. Typical torque and EMG traces during voluntary and electrically evoked contractions. Typical torque trace (black line) during
the knee extensor maximal voluntary contraction and determination of maximal activation level, as well as high- and low frequency doublets (100 Hz
and 10 Hz, respectively) and single twitch, after the mountain ultra-marathon. The black arrows indicate the timing of delivery of the stimuli. EMG is
represented with a grey line.
doi:10.1371/journal.pone.0017059.g002
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provided the opportunity to obtain a potentiated mechanical
response and so reduce the variability in activation level (%VA)
values. The ratio of the amplitude of the superimposed twitch over
the size of the control twitch was then calculated to obtain %VA as
follows:
%VA~
1{superimposedDb100Hz
controlDb100Hz

|100
The RMS values of the VL and SOL EMG activity and average
torque level were calculated during the best MVC trial over a 0.5-s
period after the torque had reached a plateau and before the
superimposed stimulation was evoked. This RMS value was then
normalized to the maximal peak-to-peak amplitude of the M-wave
(RMS?M
21).
Perceived exertion. The fatigue and pain sensations were
measured PRE, POST and over the recovery sessions on a 10-cm
visual analog scale. The subjects were requested to report their
general fatigue, KE and PF pains and digestive system feeling.
Statistics
All descriptive statistics presented in the text, tables and figures
are mean values 6 SD. Data were screened for normality of
distribution and homogeneity of variances using a Shapiro-Wilk
normality test and the Barlett’s test, respectively. When conditions
of analysis of variance (ANOVA) application were met, each study
variable was compared between the different times of measure-
ments using a paired t-test (PRE-POST, n=22) or a 1-way
(sessions: PRE-POST-D+2-D+5-D+9-D+16, n=11) ANOVA
with repeated measures for the subgroup who performed the
recovery part of the study. Newhman-Keuls post-hoc tests were
applied to determine between-means differences if the analysis of
variance revealed a significant main effect. When conditions of
application for parametric repeated-measures ANOVA were not
met, Wilcoxon test (for fatigue) or Friedman ANOVA (recovery)
was used. In that case, paired comparisons were done with
Wilcoxon test with Bonferroni corrections. Pearson’s product-
moment correlation coefficients were also calculated between
MVC decrease (average value of KE and PF) or peripheral fatigue
and the following parameters: energy cost of running, perfor-
mance, age and running experience. For all statistical analyses, a P
value of 0.05 was accepted as the level of significance. The 95%
confidence intervals (95% CI) were calculated for the relative
changes from baseline in the main neuromuscular variables, i.e.
MVC, %VA, PDb100 and Db10:100. Effect size was also calculated
for these variables using Cohen’s d. The figure 0.2 was considered
a small effect; 0.5, moderate; and 0.8, large.
Results
Performance, perceived exertion and maximal voluntary
contraction
The average (6 SD) finishing time of the subjects was 37 h
37 min65 h 51 min. All levels of performance were represented
in the group of subjects as shown by their rank ranging from 5
th to
1380
th place (of 1384 finishers). The subjects reported 15625 min
of sleeping time over the race. Poles were used by 95% of the
subjects during uphills and 86% in dowhills. The self-reported
general fatigue, KE and PF pain and digestive system sensations
are given in Figure 3A. MVC declined significantly after the race
for both muscles (P,0.001) by -35% ([95% CI: 228 to 242%],
Cohen’s d=1.85) and 239% ([95% CI: 232 to 246%], Cohen’s
d=2.88) for KE and PF, respectively. For all neuromuscular
variables, the changes due to fatigue and recovery are presented in
Figures 3, 4, and 5 and in Tables 2, 3, and 4 for the 11 subjects
who have performed the recovery but statistics are presented for
both the whole group (n=22) and the subgroup (n=11) that
performed the recovery measurements. The average changes and
effects size were similar when considered the whole group or the
subgroup that performed recovery. For instance, for MVC
changes for the 22 subjects were 232% ([95% CI: 227 to
237%], Cohen’s d=1.85) and 238% ([95% CI: 234 to 243%],
Cohen’s d=2.88) for KE and PF, respectively. Most of MVC
recovery occurred between POST and D+2, then MVC returned
progressively to baseline values for both muscles (Figure 3B and
3C).
Central and peripheral components of fatigue and
recovery
Maximal voluntary activation was significantly altered by the
MUM for both muscles (Figure 4) by 219% ([95% CI: 27t o
232%], Cohen’s d=1.55) and 26% ([95% CI: 1 to 214%],
Cohen’s d=0.92) for KE and PF, respectively. The development
of central drive alterations was more pronounced in the KE
muscle group than in PF and there was a significant correlation
between %VA changes for KE and PF (R=0.47; P,0.05). There
was no more central fatigue at D+2 (Figure 4) for any of the two
muscle groups tested. RMS ?M
21 values decreased with fatigue for
KE (P,0.001) and were back to initial values at D+2 (data not
shown). RMS ?M
21 did not change significantly for PF.
Mechanical responses to evoked doublet at high frequency
response are presented in Figure 5A and 5B for KE and PF,
respectively. The MUM significantly altered PDb100 for both
muscles by 212% ([95% CI: 27t o217%], Cohen’s d=0.84) and
220% ([95% CI: 28t o231%], Cohen’s d=1.19) for KE and
PF, respectively. The recovery kinetics for P Db100 were different
among the two muscle groups. Indeed, while no significant
difference between PRE and recovery values was observed for
PDb100 from D+2 in KE, this response was increased (, +15%)
from D+5 in PF. Figure 5C shows that low frequency fatigue (i.e.
decrease of Db10:100: 210% ([95% CI: 27t o213%], Cohen’s
d=1.14) and 28% ([95% CI: 23t o212%], Cohen’s d=0.96)
for KE and PF) was induced by the MUM and that Db10:100 was
back to initial values at D+2. Table 2 displays the main
characteristics of the mechanical (KE and PF) and EMG (VL
and SOL) responses to single electrical stimulations of the femoral
and tibial motor nerves. In particular, this table shows clear
differences between KE and PF in recovery kinetics for potentiated
peak twitch and potentiation.
No significant correlations were found between global fatigue or
peripheral alterations and age, level of performance or running
experience.
Blood analysis and body mass
The evolution of the main blood markers for muscle damage
and inflammation are presented in Table 3. The broad range of
individual CK values at POST is reported in Figure 6.
Haematocrit concentration decreased from 44.362.5 at PRE to
39.863.0% at POST (P,0.001) and was back to initial values at
D+5 (43.262.6%, not measured at D+2).
Changes in Na
+,K
+,C a
2+ and glucose concentrations are given
in Table 4. Regarding body mass, the subjects lost ,1 kg during
the MUM (from 73.866.3 to 72.8 kg, P,0.001, n=22 or from
75.166.2 to 74.365.9, P=0.11, n=11). The subjects’ body mass
went up at D+2 (75.666.3 kg, NS to compare with PRE), then
Neuromuscular Consequences of Extreme Running
PLoS ONE | www.plosone.org 5 February 2011 | Volume 6 | Issue 2 | e17059Figure 3. Self-reported general fatigue and maximal voluntary contraction on the knee extensor and plantar flexor muscles. Self-
reported general fatigue, knee extensors (KE) and plantar flexors (PF) pain and digestive system sensations (panel A) as well as maximal voluntary
contraction (MVC) on the knee extensor muscles (panel B) and on the plantar flexor muscles (panel C) before (PRE), after (POST) and 2, 5, 9 and 16
days after the race (D+2, D+5, D+9 and D+16, respectively). Data are mean values 6 SD. $$$: P,0.001, Significance of t-test between PRE and POST
(n=22). ++:P ,0.01; +++:P ,0.001, Significance level of pairwise comparisons between PRE and every other measurements (n=11) revealed by
Wilcoxon test plus Bonferroni corrections when Friedman ANOVA was significant, P,0.01 to be significant. *: P,0.05; **: P,0.01; ***: P,0.001,
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74.465.8 kg at D+5, D+9 and D+16).
Discussion
The purpose of the present study was to investigate the aetiology
of fatigue and the recovery kinetics of trained subjects performing
exercise as extreme as a mountain ultra-marathon lasting , 37.5 h.
In particular, we hypothesized that neuromuscular function
alterations, especially at the peripheral level, would be higher than
after a running exercise of similar distance without elevation change
[2]. The main results of the present study are: (i) the MVC
decreases, which were by as much as 35–40% after the race,
recovered within 9 days (25–6%), (ii) the aetiology of fatigue was
pluri-factorial and differed between knee extensors and plantar
flexors, the main two muscle groups implicated in mountain ultra-
marathons, (iii) low-frequency fatigue was detected for the first time
after prolonged running exercise and (iv) most of the biological
factors associated with tissue damage and inflammation had
returned to normal 9 days after the race. Collectively, these results
give the first picture of the physiological consequences of one of the
most extreme exercises realized by humans in race conditions.
Figure 4. Maximal voluntary activation on the knee extensor and plantar flexor muscles. Maximal voluntary activation (%VA) of the knee
extensor muscles (panel A) and the plantar flexor muscles (panel B) before (PRE), after (POST) and 2, 5, 9 and 16 days after the race (D+2, D+5, D+9
and D+16, respectively). Data are mean values 6 SD. $$$: P,0.001, Significance of Wilcoxon test between PRE and POST (n=22). ++:P ,0.01:
Significance level of pairwise comparisons between PRE and every other measurements (n=11) revealed by Wilcoxon test plus Bonferroni corrections
when Friedman ANOVA was significant, P,0.01 to be significant. Percentages indicated are for n=11.
doi:10.1371/journal.pone.0017059.g004
Significance level of pairwise comparisons between PRE and every other measurements (n=11) revealed by post-hoc analysis. Percentages indicated
are for n=11.
doi:10.1371/journal.pone.0017059.g003
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PLoS ONE | www.plosone.org 7 February 2011 | Volume 6 | Issue 2 | e17059Figure 5. Mechanical responses to the high-frequency doublets and to the low-to-high frequency doublet ratio. Maximal high
frequency doublet (Db 100 Hz) on the knee extensor muscles (panel A) and the plantar flexor muscles (panel B) as well as the low- to high-frequency
doublet ratio (10:100 ratio, panel C) before (PRE), after (POST) and 2, 5, 9 and 16 days after the race (D+2, D+5, D+9 and D+16, respectively). Data are
mean values 6 SD. Panels A and B: $$$: P,0.001, Significance of t-test between PRE and POST (n=22). *: P,0.05; **: P,0.01; ***: P,0.001,
Significance level of pairwise comparisons between PRE and every other measurements (n=11) revealed by post-hoc analysis, are indicated by
horizontal brackets). Panel C: $$$: P,0.001, Significance of Wilcoxon test between PRE and POST (n=22). ++:P ,0.01, Significance level of pairwise
comparisons between PRE and every other measurements (n=11) revealed by Wilcoxon test plus Bonferroni corrections when Friedman ANOVA was
significant. Percentages indicated are for n=11.
doi:10.1371/journal.pone.0017059.g005
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ultra-marathon
Central and peripheral alterations. The global NM
fatigue for KE agrees with the strength loss–exercise duration
relationship for running exercise [2,5]: force loss dramatically
increases as running duration increases for the first few hours,
and then it tends to plateau for extreme durations. It is attractive
to compare these results with our previous study investigating a
24 h treadmill run without slope [2] since the distance - but not
the time due to elevation change of the MUM - was comparable
(153 km vs. 166 km). Central fatigue has been consistently
demonstrated as the main explanation for neuromuscular
fatigue after ultra-endurance exercise on KE [2,6] and a recent
study suggested that this central drive reduction was not as high
for PF as for KE after a 24 h treadmill run [2]. The present
finding partially confirmed these observations since the decrease
in %VA was the main cause of KE strength loss and PF was less
affected by central fatigue (219620% vs. 26612% for KE and
PF, respectively, Fig 5A and 5B). Nevertheless, higher levels of
central fatigue were expected in the present study due to the
longer duration of exercise. Although the amplitude of central
drive reduction was lower for PF muscles than for KE, there was
a significant correlation between %VA changes for KE and PF,
in line with the 24 h study [2]. This result could reflect the
existence of a common central mechanism aimed at reducing
neural input to working muscles to limit fatigue and damage
[17,18]. This safety mechanism may nevertheless be activated by
peripheral feedback from muscle afferents [19] directly at the
supraspinal level [20] or at the spinal level. Hyponatremia and
hypoglycaemia were not observed among our subjects (Table 4).
Thus, their implication in the generation of central fatigue can be
excluded. Hyponatremia has been previously reported in
prolonged running, probably because runners have been
recently encouraged to overdrink during races [21]. Two
factors could explain why this was not the case in the present
race: (i) temperature was not as high as in other famous ultra-
marathons like the Comrades or the Western States 100 miles
thus runners probably did not drink as much and (ii) warm salted
soups are served at every aid station and are usually appreciated
by runners. Hypoglycaemia was not observed in the present study
but glucose concentration changes must nevertheless be
interpreted with caution since carbohydrate ingestion at the
finish line was not controlled.
While intrinsic force (i.e. force induced by MVC + superim-
posed tetanus, [2]) was not assessed in the present study, large
peripheral alterations have been evidenced by the alterations of
the absolute high frequency doublet, M-wave alterations (lower
amplitude and longer duration) and the existence of LFF.
Peripheral alterations were more pronounced in the present
study than in the 24 h run experiment, likely due to long downhill
sections (i.e. eccentric contractions of KE and PF) during the
MUM. LFF has been linked to failure of excitation-contraction
coupling [11]. This result is interesting since we and others have
not been able to detect any LFF after prolonged running,
Table 2. Changes from baseline in potentiated peak twitch of knee extensors (KE) and plantar flexors (PF) and M-wave
characteristics of Vastus Lateralis (VL) and Soleus (SOL) muscles.
POST D+2D +5D +9D +16
Potentiated Peak Twitch
KE 222%
$$$,*** 29%
** 25%
p=0.07 25%
p=0.06 24%
*
[228 to 217%] [213 to 24%] [210 to 21%] [29t o22%] [210 to 1%]
PF 220%
$$$, *** +4% +15%
* +17%
* +16%
**
[231 to 28%] [28t o1 6 % ] [ 231 to 1%] [4 to 29%] [227 to 5%]
M-wave Peak-to-peak Amplitude
VL 219%
$$$,*** 219%
*** 22% +3% +8%
[228 to 210%] [225 to 212%] [211 to 7%] [26t o1 2 % ] [ 21 to 16%]
SOL 220%
$$, p=0.09 236%
p=0.02 0% +9% 22%
[235 to 24%] [245 to 226%] [221 to 22%] [223 to 40%] [234 to 29%]
M-wave Peak-to-peak Duration
VL +14%
$, p=0.06 +10%
p=0.07 +7% +10% +15%
p=0.05
[3 to 25%] [3 to 17%] [21 to 16%] [22 to 21%] [0 to 29%]
SOL +12%
p=0.06 +11% +3% 25% 0%
[24 to 29%] [26t o2 7 % ] [ 213 to 20%] [218 to 7%] [212 to 12%]
Data are expressed as D changes from PRE values (n=11). Data are mean values 6 SD. 95% Confidence Intervals are given in square brackets.
POST/D+2/D+5/D+9/D+16 are the measurements performed immediately after and 2, 5, 9 and 16 days after the race.
$:P ,0.05,
$$:P ,0.01,
$$$:P ,0.001,
significance of t-test between PRE and POST (n=22);
*: P,0.05;
**: P,0.01;
***: P,0.001,
significance level of pairwise comparisons between PRE and every other measurements (parametric tests).
+++:P ,0.001,
significance level of pairwise comparisons between PRE and every other measurement (nonparametric tests, P,0.01 to be significant). D changes from PRE values in
potentiated twitch contraction time, potentiated twitch half-relaxation time and potentiation of knee extensors (KE) and plantar flexors (PF) are given in File S1.
doi:10.1371/journal.pone.0017059.t002
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LFF generally occurs after exercise inducing muscle damage (e.g.
[22]), which is the case after prolonged running [23]. As a result,
we recently suggested that minimal exercise intensity is necessary
to induce mechanical and metabolic disturbances that may
promote the development of LFF [2]. The findings of the present
study suggest that extremely long eccentric exercise (total
negative elevation was higher than going from the top of Mount
Everest to sea level in less than two days) at low intensity may be
sufficient to trigger LFF, as is the case for much shorter distance
but higher intensity (combination of negative slope and speed)
downhill running [24]. Of note is that LFF existed in the present
study and not in the 24 h run while plasma indexes of muscle
damage (e.g. 13,633 vs. 13,319 UI ? L
21 for CK) and global
fatigue (strength losses) were comparable.
Knee extensor vs. plantar flexor fatigue. Contrary to what
we expected from subjectively reported runners’ experience, which
was confirmed here by visual analog scale measurements (i.e.
higher pain for KE than for PF, Figure 3A), strength losses were
higher for PF than for KE, despite a relatively preserved activation
(Figure 4B). Large peripheral fatigue was observed for PF, as
demonstrated by the 20% decrease in Pdb100, a strong tendency
toward LFF and M-wave alteration. It is interesting to note that
while subjective pain was lower for PF, the slope of recovery for
this variable was lower than for KE, suggesting long-lasting
damage.
The relative contribution of PF and KE muscles probably also
depends on the runner’s level of performance and training
background or the runner’s technique. We hypothesized that,
compared with a flat ultra-marathon [2], fatigue would be lower
for PF because of elevation changes. In fact, it has been shown that
the PF muscles are more active than KE during slow running on
flat terrain, e.g. there was significantly greater muscle glycogen
utilization in the calf than in the thigh [25]. The relative
contribution of the two muscle groups in level vs. uphill running
may however depend on the speed [26] so that the two vastii and
the rectus femoris muscles are more active in uphill running at
high speed, a situation not experienced by the runners during the
MUM. Most of the uphills were actually performed walking
during the MUM. For this type of locomotion, the major change
due to slope is a greater contribution of hip extensors [27], a
muscle group not studied in the present experiment. In addition, it
is likely that the use of poles modifies the relative contribution of
different muscle groups [28]. Since studies on marathon [29] and
ultra-marathon [2] on flat surfaces reported higher MVC
decrements for KE than PF, it was hypothesized [2] that KE
was less resistant to fatigue than PF, potentially due to a lower
percentage of type I fibers. The present data demonstrate that it is
not a general rule.
Biological markers of fatigue. As expected, the MUM
induced large effects on blood markers of muscle damage and
inflammation (Table 3). Of particular interest is the large
variability among subjects in these responses, e.g. in CK activity
(Figure 6), which has already been observed [2].The comparison
of these different markers with the literature shows that the MUM
was extremely taxing. For instance, peak CK activities have been
reported to be ,4,500, ,2,700 and , 5000 UI ? L
21 after races
of 1600-km [30], 200-km [31] and 100 km [12], respectively.
These are much lower than the values measured in the present
study (,13,600 UI ? L
21 at POST; n=22). Such activity levels are
similar to those measured in patients undergoing severe
rhabdomyolysis [32] but very rarely led to hospitalization. One
exception was noted the year before the present experiment in the
same race (North-Face Ultra-Trail du Mont-blancH) when one
subject went to an intensive care unit for dialysis [33]. CK activity
was measured at 429 240 UI ? L
21 in this subject but it was
eventually found that extreme exercise was combined with the use
of nonsteroidal anti-inflammatory drugs the week preceding the
race and dehydration due to diarrhea. The two subjects with CK
values above 45000 UI ? L
21 (Figure 6B) did not have particular
health troubles. The incidence of hospitalization may thus be
secondary to inappropriate use of pharmaceutical. Nevertheless,
we were able to get blood from one of our subjects who did not
finish because he was stopped by a medical doctor of the race due
to dark urine. His CK activity was 7126 UI ? L
21 but his Mb
concentration was 2308 mg ? L
21. Interestingly, the markers of
muscle damage and inflammation in the present study were lower
than those consistently observed after the Spartathlon race, a 246-
km continuous race from Athens to Sparta (Greece). In fact, while
finishing times are similar for the Spartathlon and the North-Face
Ultra-Trail du Mont-blancH, higher concentrations of LDH, CK,
CRP and total white blood cells have been reported after the
Spartathlon compared with the present findings [32,34,35]. We
hypothesized that the combination of surface (road, i.e. stiffer
Table 3. Main blood markers of muscle damage and
inflammation.
PRE POST D+2D +5D +9D +16
Creatine Kinase Activity (UI ? L
21)
124 15775
$$$, ++ 3276
++ 313
++ 108 116
668 617166 63848 6263 654 649
Myoglobin (mg ? L
21)
28 1730
$$$, ++ 81
++ 41
p=0.01 24 25
613 61482 663 623 611 611
Lactate Dehydrogenase (UI ? L
21)
330 1448
$$, ++ 1002
++ 774
++ 469
p=0.01 369
667 61110 6594 6470 6228 6118
C-Reactive Protein (mg ? L
21)
2.0 46.8
$$$, ++ 30.0
++ 7.2
++ 2.5 2.3
60.0
a 624.8 619.7 63.7 61.2 60.6
Leucocytes (mm
23)
6218 10773
$$$,*** / 5440 / /
61359 62473 / 6971 / /
Creatinine (mmol ? L
21)
84.8 90.7
$$ 75.5
** 78.2
p=0.06 79.5
p=0.07 79.8
p=0.12
613.0 616.1 613.2 610.1 614.0 613.0
Data are mean values 6 SD (n=11). PRE/POST/D+2/D+5/D+9/D+16 are the
measurements performed immediately before, after and 2, 5, 9 and 16 days
after the race.
$$:P ,0.01,
$$$:P,0.001,
significance of t-test between PRE and POST (n=22).
**:P,0.01;
***: P,0.001,
significance level of pairwise comparisons between PRE and every other
measurements (parametric tests).
++:P ,0.01,
+++:P ,0.001,
significance level of pairwise comparisons between PRE and every other
measurement (nonparametric tests, P,0.01 to be significant).
a: For C-reactive protein, data ,2m g? L
21 were noted 2 mg ? L
21. Values of
total proteins, urea, aspartate aminotransferase and alanine aminotransferase
as well as D changes from PRE values, Cohen’s d and 95% Confidence Intervals
are given in File S2.
doi:10.1371/journal.pone.0017059.t003
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temperature (up to 36uC) could explain these observations.
table-2-captionIn the present study, there was a significant
decrease in [K
+] and [Ca
2+] after the MUM in the present study.
This differs with the data of Martin et al. [2] where no significant
change in plasma [K
+] was observed after a 24 h run and with the
data of Overgaard et al. [12] showing a significant increase in
plasma K
+ from 4.0 to 5.5 mmol ? L
21 after a 100-km run. This
discrepancy might be explained by the haemodilution shown by
subjects having nearly 5% lower haematocrit concentration and
the significant decrease of total protein at POST in the present
study. This is in line with data showing that 4 days of prolonged
exercise (5 h per day) induced a transient plasma volume
expansion [36]. Large increases in plasma volume have also been
reported after a 1600-km ultra-marathon [30], after a 24-h
endurance race [37] and after an ultramarathon cycling [38].
However, such haemodilution was found neither after the
Spartathlon [32] nor after the Comrades ultra-marathon, a 90-
km road race in South Africa [39]. However, these races (i) were
run at higher external temperatures, likely leading to dehydration
[32] and (ii) were shorter, i.e. the runners were running faster and
hence sweating more.
Recovery kinetics
Ultra-marathons are increasingly popular but their physiolog-
ical consequences and possible negative effects on runners’ health
are poorly understood. To the best of our knowledge, no
epidemiologic data exist on ultra-marathon runners and experi-
mental data about recovery after extreme duration exercise are
extremely scarce. One major interest of the present study was thus
to describe the recovery kinetics of neuromuscular function and
blood markers over 16 days after the MUM. Most of the indexes of
neuromuscular function evaluated in the present study recovered
within 9 days after the MUM. Some exceptions are potentiated Pt
and potentiation for KE, both factors still depreciated at D+16.
There was also a tendency toward a longer vastus lateralis M-wave
peak-to-peak duration at D+16. Even if recovery of neuromuscular
function does not necessarily mean that functional capabilities
have returned to normal since no information about endurance/
metabolic properties are given in the present study, it is interesting
to report that strength losses have been reported for much longer
period after short- and intense eccentric exercise [e.g. [40,41],
mostly on upper body muscles] than after the MUM studied here.
Maximal voluntary activation was back to baseline values at
D+2. This is in line with previous studies on different types of
Figure 6. Individual creatine kinase activities. Individual creatine kinase activities (CK) before (PRE, panel A) and after (POST, panel B) the
mountain ultra-marathon. Note the different scale.
doi:10.1371/journal.pone.0017059.g006
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or eccentric/stretch-shortening cycle exercise (e.g. [22]) where
maximal activation was found to be back to baseline values as
soon as one day post-exercise. It has been suggested that high
central fatigue due to prolonged running is not due solely to
central nervous system biochemical changes but that afferent
fibers are probably involved [5] via direct or indirect inhibition
from III-IV afferent fibers and disfacilitation of Ia afferent. It is
known that group III-IV afferent fibers are sensitized by the
production of pro-inflammatory mediators (e.g. [43]). It is thus
tempting to speculate about the effects of the inflammation found
in the present study (elevated serum CRP concentration and
leucocytes concentration) on the activation of group III and IV
afferent fibers and their potential effect on descending neural
drive. However, our data are too limited to give a precise
description of the inflammatory processes that might explain
changes in central fatigue.
The recovery of peripheral fatigue showed different patterns for
the two muscle groups and the different characteristics investigated
here. M-wave was still depreciated at D+2 for both PF and KE.
One hypothesis is that the EMG measurement was affected by
oedema existing at D+2, as clinically observed and suggested by
the significantly higher body mass at this time point.
Contrary to M-wave characteristics, LFF had recovered
baseline values at D+2, suggesting that excitation-contraction
coupling was not altered from a statistical point of view two days
after the MUM. Forty-eight hours after a one-legged downhill run,
severe eccentric exercise which induced marked LFF, Martin et al.
[22] found that this variable had completely recovered. This result
has since been confirmed for other eccentric exercise [44,45] but
no data exist for an exercise similar to the MUM. Raastad et al.
[44] recently suggested that myofibrillar disruptions, rather than
alteration-contraction coupling failure, seem to be a main cause
for the long-lasting reduction in force-generating capacity after
eccentric exercise. It is yet important to highlight here that
potentiated twitch and potentiation were still depreciated at D+16
suggesting that the E-C was not completely back to normal 2
weeks after the MUM.
As tetanus was not evoked in the present study, it was not
possible to assess the alteration and recovery of the intrinsic force-
generating capacity of the muscle. However, it must be noted that
the high-frequency doublets completely recovered at D+2 and
stayed a pre-race values until D+16 (Figure 5A) for KE. An
interesting result was that electrically evoked PF single twitch and
doublets increased by about 15% from D+5t oD +16 (see Figure 5B
and Table 2) while MVC was similar to PRE values for this muscle
group at the same times. This was accompanied by a tendency
toward a longer half-relaxation time for this muscle, suggesting a
depreciated Ca
2+ reuptake more than 2 weeks after the MUM.
These surprising findings might also be linked to increased PF
stiffness that could artificially increase mechanical responses to
evoked single or double stimulations without necessarily affecting
MVC. The fact that these increased evoked responses during
recovery were limited to PF could be related to the higher
peripheral fatigue for this muscle group compared with KE but
muscle specificity in terms of tendon/muscle ratio cannot be ruled
out. Altogether, this suggests that some intra-muscular mecha-
nisms might not be completely normal. This surprising finding
clearly requires further investigation.
The recovery kinetics of CK and LDH were in line with the
literature [12]. It has been suggested that not only eccentric
exercise but also prolonged running exercise [12] can lead to an
increase in cytoplasmic Ca
2+ and that elevated resting Ca
2+ levels
may activate proteolytic enzymes such as calpain to digest
structural elements of fibers. In this context, it is important to
report that plasmatic [Ca
2+] was still reduced at D+2 even if this
latter result may be linked to lower total proteins. In summary, no
single neuromuscular step (from voluntary activation to contractile
processes) can explain the lower MVC in the days after the MUM.
It is likely that, as for neuromuscular fatigue, the recovery process
is multi-factorial.
The purpose of this experiment was to document the
physiological consequences of an exercise probably among the
hardest performed all over the world in competition. It is
concluded that the large alterations of neuromuscular function
after an ultra-marathon race are multi-factorial and dependant
on the muscle group in consideration. This study is the first to
detect the existence of low-frequency fatigue after prolonged
running, likely due to the 9500 m of negative change in altitude.
As early as two weeks after such an extreme running event,
maximal force capacities have returned to baseline but it is likely
that neuromuscular measurements do not fully describe the
recovery process of an athlete. We believe that the present paper
is an important contribution but it must be seen as a first step
toward comprehension of the physiological consequences of
exercise as extreme as mountain ultra-marathons. Further works
are now required to explain the influence of gender [46], age or
weather conditions [47] in performance and odds of finishing in
this type of extreme event. More experimental (focusing for
instance on cartilage and tendon injuries) or epidemiologic
studies are also required to understand whether the balance of
risks/benefits is positive for this type of event and to help
medical doctors and physiotherapists to assist athletes and
coaches.
Table 4. Sodium (Na
+), potassium (K
+), calcium (Ca
2+) and
blood glucose concentrations.
PRE POST D+2D +5D +9D +16
Na
+ (mmol ? L
21)
140.5 140.2 141.1 140.3 140.4 141.0
61.4 62.6 62.6 62.0 61.9 61.7
K
+ (mmol ? L
21)
4.3 3.8
$$$, ++ 4.2 4.4 4.2 4.2
60.3 60.2 60.3 60.2 60.2 60.4
Ca
2+ (mmol ? L
21)
2.51 2.40
$$$, *** 2.30
*** 2.47 2.48 2.51
60.04 60.08 60.07 60.04 60.07 60.06
Glucose (mmol ? L
21)
4.9 7.6
$$$, ** 4.9 5.0 4.8 4.9
60.5 61.5 60.9 60.6 60.6 60.8
Data are mean values 6 SD (n=11). PRE/POST/D+2/D+5/D+9/D+16 are the
measurements performed immediately before, after and 2, 5, 9 and 16 days
after the race.
$$:P ,0.01,
$$$:P,0.001,
significance of t-test between PRE and POST (n=22).
**:P,0.01;
***: P,0.001, significance level of pairwise comparisons between PRE and every
other measurements (parametric tests).
++:P ,0.01,
significance level of pairwise comparisons between PRE and every other
measurement (nonparametric tests, P,0.01 to be significant).
a: For C-reactive protein, data ,2m g? L
21 were noted 2 mg ? L
21. D changes
from PRE values, Cohen’s d and 95% Confidence Intervals are given in File S3.
doi:10.1371/journal.pone.0017059.t004
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